Why the study?
Women with T2DM have an increased susceptibility to cardio-renal disease compared to men, but the reasons and mechanisms of this vulnerability remain unclear.
Are there sex differences in glutathione peroxidase activity and central obesity in patients with type 2 diabetes at high risk of cardio-renal disease?
Are there sex differences in glutathione peroxidase activity and central obesity in patients with type 2 diabetes at high risk of cardio-renal disease?
Increased central fat deposits in T2DM patients are associated with reduced plasma antioxidants, though women exhibit higher GPx-3 activity potentially as a preserved response to visceral fat.
Sex differences in antioxidant status among high-risk T2DM patients; leaves open whether oxidative stress modulation alters cardio-renal outcomes in women.
Women with type 2 diabetes (T2DM) have an increased susceptibility of developing cardio-renal disease compared to men, the reasons and the mechanisms of this vulnerability are unclear. Since oxidative stress plays a key role in the development of cardio-renal disease, we investigated the relationship between sex, plasma antioxidants status (glutathione peroxidase (GPx-3 activity), vitamin E and selenium), and adiposity in patients with T2DM at high risk of cardio-renal disease. Women compared to men had higher GPx-3 activity (p = 0.02), bio-impedance (p ≤ 0.0001), and an increase in waist circumference in relation to recommended cut off-points (p = 0.0001). Waist circumference and BMI were negatively correlated with GPx-3 activity (p ≤ 0.05 and p ≤ 0.01, respectively) and selenium concentration (p ≤ 0.01 and p ≤ 0.02, respectively). In multiple regression analysis, waist circumference and sex were independent predictors of GPx-3 activity (p ≤ 0.05 and p ≤ 0.05, respectively). The data suggest that increased central fat deposits are associated with reduced plasma antioxidants which could contribute to the future risk of cardio-renal disease. The increased GPx-3 activity in women could represent a preserved response to the disproportionate increase in visceral fat. Future studies should be aimed at evaluating if the modulation of GPx-3 activity reduces cardio-renal risk in men and women with T2DM.
No takes yet. Share an insight, caveat, or question.
Steyn et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: